Trial NCT00581477

View at ClinicalTrials.gov 
Org. Study IDs: 030750
Secondary IDs: P01HL056693

Last trial update was posted on 2022-03-02

MeSH Interventions

Droxidopa

MeSH Conditions

Autonomic Nervous System Diseases Hypotension Hypotension, Orthostatic Nervous System Diseases Orthostatic Intolerance Primary Dysautonomias

Other Conditions

Dopamine Beta-Hydroxylase Deficiency Orthostatic Hypotension

Stopping Reasons

1. enrollment slower than anticipated; 2. FDA approval of droxidopa so no longer need to treat patients on research basis; 3. personnel who were primarily responsible for the study are no longer at Vanderbilt.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID